EagleClaw Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $3.24M | Sell |
|
|||||
|
2024
Q1 | $4.28M | Sell |
|
|||||
|
2023
Q4 | $3.81M | Sell |
|
|||||
|
2023
Q3 | $4.07M | Buy |
|
|||||
|
2023
Q2 | $4.29M | Buy |
|
|||||
|
2023
Q1 | $3.73M | Buy |
|
|||||
|
2022
Q4 | $3.92M | Sell |
|
|||||
|
2022
Q3 | $4.77M | Buy |
|
|||||
|
2022
Q2 | $3.15M | Buy |
|
|||||
|
2022
Q1 | $4.01M | Buy |
|
|||||
|
2021
Q4 | $1.5M | Buy |
|